From our symposium - Scaling Omics Approaches to Population Size: the unedited talk of Anders H. Kverneland, National Center for Cancer Immune Therapy. One of six young researchers selected from submitted abstracts to give a talk. On the topic: Clinical potential of adoptive cell therapy with tumor infiltrating lymphocytes therapy in combination with checkpoint inhibitors in non-melanoma patients